Revolutionizing Therapeutics through Advanced Drug Design & Delivery

Unlocking the Untapped Potential of Existing Compounds to Cure Acute and Chronic Diseases

Who We Are

ConViCure is an innovative biopharmaceutical company founded by a Stanford Professor specializing in optimizing drug delivery and reformulating existing, approved compounds to develop treatments for acute brain injury, TBI, neurodegenerative disorders, ALS, COVID-19, respiratory illnesses, Lyme disease, and more. Our approach saves valuable time and resources by leveraging existing knowledge of approved drugs, and harnessing their potential through advanced drug delivery techniques.

Our Expertise

At ConViCure, we focus on improving the pharmacokinetics of promising compounds to enhance their effectiveness. Our state-of-the-art laboratories and specialized tools enable us to deliver optimal results. We also offer Contract Research Organization (CRO) services for formulation and efficacy studies to help other companies and researchers advance their therapeutic innovations.